Mr. Ahumada has been with Hôpital Charles Lemoyne since 2021. He obtained his bachelor's degree in physics from the Université de Montréal, as well as a CAMPEP master's degree in medical physics at the same institution.

Dr. Bahoric completed his medical school in Rijeka, Croatia. He completed his Royal College Fellowship Program in Radiation oncology in Toronto. He works as staff radiation oncologist at the Jewish General Hospital in Montreal. He is assistant professor at McGill University. Apart from teaching he is involved in various administrative activities. His areas of interest and expertise are the gynecological, genitourinary and hematological malignancies. Particularly, he is interested in brachytherapy. He offers both intracavitary and interstitial for gynecological malignancies. He performs adjuvant accelerated partial breast irradiation via interstitial brachytherapy. Dr. Bahoric participates in nationwide studies in prostate cancer. As part of the studies he offers and performs HDR prostate brachytherapy. He is past president of Canadian Brachytherapy Group and is still active participant in this group.

Yannick Chassé graduated from Ahuntsic College in 2013 and his a member of the brachytherapy team at the Hôpital Charles Lemoyne since 2020.

Dr Crook did her medical training at the University of Toronto, Residency in Radiation Oncology at the Princess Margaret Hospital and is currently a Full Professor of Radiation Oncology at the University of British Columbia. She is a staff Radiation Oncologist in Kelowna BC where she has developed image-guided HDR gynecologic brachytherapy, US-planned HDR prostate brachytherapy, HDR interstitial and surface mold penile brachytherapy and permanent seed brachytherapy for breast cancer. She is former president of the Board of the American Brachytherapy Society, recipient of the Thom Shanahan Distinguished Brachytherapy Educator Award and the ABS 2017 Henschke Award. She is also the first to hold a Brachytherapy Research Chair position in British Columbia.

Dr Derashodian is a radiation oncologist working at BC Cancer Kelowna.. She graduated from Université de Montreal’s medical school in 2005. She then completed her residency in radiation oncology at Université Laval. She pursued her academic training at University of Miami with a fellowship in Urologic cancers under the supervision of Dr Alan Pollack. She then started her practice at Centre Intégré de Cancérologie de la Montérégie, at Charles LeMoyne hospital, and gained expertise in general brachytherapy.  Her main areas of expertise include urologic, gynecologic, and skin cancer, as well as general brachytherapy.

Phillip M. Devlin, MD, FACR, FASTRO, FFRRCSI(Hon) is Associate Professor of Radiation Oncology at Harvard Medical School and Chief of the Division of Brachytherapy in the Department of Radiation Oncology at the Dana-Farber/Brigham and Women’s Cancer Center. Dr. Devlin earned his medical degree at the University of Virginia School of Medicine in 1991 and completed his residency in Radiation Oncology at the University of Pennsylvania in 1995, followed by a specialized fellowship in brachytherapy at Memorial Sloan-Kettering Cancer Center in 1996.   In addition to lecturing extensively both nationally and internationally, Dr. Devlin has more than 100 published manuscripts and book chapters, and is editor of the text, Brachytherapy: Applications and Techniques, now in its second edition. He is a past President of the Massachusetts Radiological Society and was previously a member of the Board of Directors of the American Society for Radiation Oncology (ASTRO). In 2008, he was named a Fellow of the American College of Radiology (FACR), and in 2013 he became both a Fellow of ASTRO (FASTRO) and a Faculty of Radiology Honorary Fellow in the Royal College of Surgeons of Ireland (FFRRCSI[Hon]) and a Fellow of the American Brachytherapy Society. Dr. Devlin led two funded studies as part of the ACR’s Quality Research in Radiation Oncology (QRRO) project. His current research focus is on radioreponsiveness and gene expression in cutaneous lymphoma treated with brachytherapy. He continues to lead internationally in developing and deploying innovative brachytherapy techniques to expand the scope of practice, teaching and research.  

Dr. Corrinne Doll is a Clinical Professor in the Departement of Oncology at the. University of Calgary and Radiation Oncologist at Arthur Child Comprehensive Cancer Center.  She is translational research and clinical gynecologic brachytherapy lead, division of Radiation Oncology, deputy medical director of the Arthur Child Comprehensive Cancer Center and associate director of clinical and population research for the Charbonneau Cancer Institute.  She served two terms as co-chair of the cervical canccer working group of the Canadian Clinivsl Trials Group and is an Executive Committee member of the CCTG Gyn Disease site group.  She served as Special Expert of the NCI Gynecologic Cancer Steering cinnuttee and co-chairm NCI NIH Cervical Cancer task force.  In addition she is past-president of the Canadian Association of Radiation Oncology.  Her clionical and research areas are in gastrointestinal and gynecologic cancer.  This includes clinical trials investigating clinical and molecular factors of treatment resistance in cervical and anal cancers, and investigation of me microbiome in patients with cervical cancer.

...

Dr. I-Chow "Joe" Hsu is an internationally recognized radiation oncologist with special expertises in brachytherapy and hyperthermia. Dr. Hsu’s research investigates the application of Hight Dose Rate (HDR) brachytherapy, a highly precise and conformal treatment that delivers radiotherapy by temporarily placing a minute radioactive source in the tumor using minimal invasive, image guided procedures.  His research in hyperthermia, a moderate temperature elevation (40-45° C) of the targeted tumor, explores the synergy between thermal therapy and radiotherapy to improve treatment efficacy without increasing treatment related toxicity.  His research in the treatment of genitourinary and gynecologic malignancies have lead to improved clinical outcomes and effective novel treatments for challenging clinical conditions. Dr. Hsu earned a medical degree at the Johns Hopkins School of Medicine. He is an active member of American Society for Radiation Oncology, American Brachytherapy Society and Society for Thermal Medicine.  He has been recognized as a Fellow of American College of Radiology and as a Fellow of American Society for Radiation Oncology.

Dr. Fleur Huang is a radiation oncologist at the Cross Cancer Institute in Edmonton, and Associate Professor in the Department of Oncology at the University of Alberta, where she is a member of the Women and Children’s Health Research Institute. She maintains a busy clinical practice, focused on women's cancers and palliative radiotherapy. Dr. Huang holds a medical degree from McGill University, where she also completed residency in Radiation Oncology. This was followed by Breast and Gynecologic subspecialty training at the Princess Margaret Hospital. With growing clinical experience came deepening professional interests in Global Health and Health Systems, and she earned an MPH at the Johns Hopkins Bloomberg School of Public Health. Dr. Huang is a core member of CancerCare Alberta’s Brachytherapy Centre of Excellence working group, advancing and advocating for brachytherapy care and research from the trenches. Recent multidisciplinary forays have explored house-made MRI-based uterine deformation and normal tissue autocontouring deep learning tools, and first-in-kind prototyping of a virtual reality simulator for cervical brachytherapy intracavitary/interstitial applicator insertion. She has been participating in the EMBRACE Collaborative Group (www.embracestudy.dk) since her first study enrolment in 2011, and still leads the team that was among the top-10 accruers to EMBRACE-I and EMBRACE-II.

Dr. Marjory Jolicoeur studied at Université de Montréal for a an MD, PhD degree.  She founded Curietherapies in 2012, a non-profit organization that she still presides over today. A renowned radiation oncologist, she completed her residency at Université de Montreal in 1996, before completing a brachytherapy fellowship at the Centre Georges-François Leclerc located in Dijon (France). In 1997, she started working at the department of Radiation Oncology of Université de Montréal, where she still teaches. A mere two years later, she was appointed medical consultant for all planning, construction and equipment selection processes of the new Radiation Oncology department of Hospital Charles-Le Moyne. She innovates by equipping the department with a suite and a comprehensive image-guided brachytherapy program. As a brachytherapy specialist, she has special research interests in its application to pathologies such as breast, genitourinary and gynecologic cancers. Her main focus is on the development of image guided implant procedures, the use of MRI in brachytherapy and the precision delivery of conformal high dose rate brachytherapy. She also teaches brachytherapy nationally and internationally.  She is also a recipient of the Jean Roy  Brachytherapy Award of 2021. 

Andrée Jutras graduated from Ahuntsic College in 1994.  She has been a member of the brachytherapy team at the Centre Hospitalier de l'Université de Montréal since 2005 and has been Chief Brachytherapy Technologist since 2017.

Dr Lagmago completed his PhD in Atomic and Molecular Physics at Institut de Mathématiques de Sciences Physiques (Bénin) and Université Catholique de Louvain (Belgium). He was postdoctoral research associate for 3 years at the University of Nebrasla-Lincon (USA) and a reseach associate for 3 years at the University of Sherbrooke (Canada). He later completed a Masters in Medical Physics at McGill University and a residency in Medical Physics at the Ottawa Hospital (Ontario, Canada). He is a member of the Canadian College of Physicists in Medicine and has been working as a clinical medical Physicist at Hospital Charles-Lemoyne since 2010. His area of interest and expertise are in brachytherapy, accelerator quality assurance and dosimetry.

Eric Leung is a radiation oncologist and GYN Radiation Site Lead at Sunnybrook Odette Cancer Centre and Associate Professor at the University of Toronto, Department of Radiation Oncology. He is the Co-Chair of the Canadian Clinical Trials Group (CCTG) cervix working group, a member of the NRG Oncology Cervix Core Committee and sits on the NCI Cervical Cancer Task Force. He is the University of Toronto Department of Radiation Oncology Fellowship Director for the Brachytherapy AFC Program and is an Associate Editor for Brachytherapy and the Red Journal.

Fellowship en curiethérapie; Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA MSc médecine expérimentale; Faculté de médecine, University Laval, Québec, Québec “Diplôme d’étude supérieurs en radio-oncologie”; University Laval, Québec, Québec Doctorat en médecine; Faculté de médecine, Université Laval, Québec, Québec Bachelier en Pharmacie; École de pharmacie, Université Laval, Québec, Québec

Alvaro A. Martinez, M.D. received his medical degree from Universidad Javeriana in Bogota, Colombia. He completed a radiation oncology residency program at the Memorial Sloan-Kettering Cancer Center in New York. Following his residency, he became an Assistant Professor at Stanford University Medical School in Palo Alto, California. In 1981, he joined the department of Oncology at Mayo Clinic Medical School in Rochester, Minnesota where he achieved the position of Associate Professor. He was appointed Chairman of the department of Radiation Oncology at Beaumont Hospital Royal Oak, Michigan in 1985 where he was a Professor of Radiation Oncology at Oakland University William Beaumont Medical school. For the past five years, he has been a Senior VP of Scientific and Clinical Strategy at 21st Century Oncology of Michigan, a division of Michigan Health care professionals. Taking advantage of his surgical training, Dr. Martinez achieved outstanding expertise in brachytherapy and he designed special applicators which are widely used for the treatment of patients with gynecological and other pelvic malignancies. He is a member of numerous national and international professional organizations and is highly regarded by his peers for his professional accomplishments. He was president of the Michigan Society of Therapeutic Radiology in 1989 and president of the American Brachytherapy Society in 1991. Dr. Martinez is certified in radiation oncology by the American Board of Radiology and was awarded a fellowship in the American College of Radiology. Dr. Martinez has been a member of several National Cancer Institute review committees. He has been an associate editor for many national and international medical journals, and has contributed to more than 340 articles in prestigious scientific medical journals. In additional, he has written and contributed to more than 45 chapters in textbooks.

Geetha Menon is a Senior Medical Physicist at the Cross Cancer Institute, Edmonton, AB and anAssociate Clinical Professor in the Department of Oncology, University of Alberta. She is a Fellow of theCanadian College of Physicists in Medicine (CCPM). Over the years, her clinical focus has been inbrachytherapy and women’s cancers. Her principal research interests are in gynecological, ocular, andprostate brachytherapy, which have resulted in many innovative research initiatives. She has been thelocal physics lead for the EMBRACE studies. In the last 10 years, she has received various grants andher multidisciplinary partnership has resulted in several peer-reviewed journal articles. She currentlyserves the Registrar on the CCPM Board. Dr. Menon is also an active member of the CanadianOrganization of Medical Physicists’ Women’s Committee and IDEA group.

Dr. Gerard Morton is a radiation oncologist at the Sunnybrook Odette Cancer Centre and an associate professor at the University of Toronto.  He has a clinical and academic focus in prostate cancer and brachytherapy, is program director of the University of Toronto Brachytherapy AFC training program, and is chair of the Royal College Brachytherapy AFC committee.  He co-chairs several ongoing multicentre clinical trials, is co-chair of the ASTRO Annual Meeting GU Track, and is North American Editor for Clinical Oncology.  He has published extensively on prostate cancer.   ...

Alexandra Rink is a Lead Brachytherapy Physicist at the Princess Margaret Cancer Centre, a member of Ontario Health Gynecological Cancers Community of Practice, and an Assistant Professor in the Departments of Radiation Oncology and Medical Biophysics, at the University of Toronto. She completed her Ph.D. in the Department of Medical Biophysics under the co-supervision of Drs. Jaffray and Vitkin in 2008, focusing on in vivo methods for patient dosimetry.  After completing her Medical Physics residency at the University of Toronto, she joined the Medical Physics department at the Princess Margaret Cancer Centre in 2010. Alexandra’s passions are in vivo dosimetry and improvement in quality of care for brachytherapy patients through the application of Artificial Intelligence and Deep Learning methods. 

...

Vincent Turgeon is a medical physicist certified by the Canadian College of Physicists in Medicine since 2021. He completed his Master's degree in Medical Physics at McGill University, where he had the opportunity to work under the supervision of Professor Shirin Enger, a leading researcher in the field. After graduating, Vincent Turgeon completed his residency in medical physics at the Jewish General Hospital, where he acquired valuable expertise. He worked with dedication